Syneron Medical Ltd
ELOS
ELOS was delisted on the 14th of July, 2017.
68 hedge funds and large institutions have $252M invested in Syneron Medical Ltd in 2014 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 19 increasing their positions, 15 reducing their positions, and 10 closing their positions.
40% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 10
27% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 15
5% more funds holding
Funds holding: 65 → 68 (+3)
7% less capital invested
Capital invested by funds: $270M → $252M (-$18M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SAM
Senzar Asset Management
New York
|
+$2.9M |
| 2 |
DGHMC
Dalton, Greiner, Hartman, Maher & Co
New York
|
+$1.65M |
| 3 |
Millennium Management
New York
|
+$908K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$549K |
| 5 |
IHM
Iguana Healthcare Management
New York
|
+$530K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BG
Baupost Group
Boston,
Massachusetts
|
-$5.58M |
| 2 |
JP Morgan Chase
New York
|
-$1.74M |
| 3 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
-$1.46M |
| 4 |
RA
Royce & Associates
New York
|
-$1.02M |
| 5 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
-$945K |
ELOS Hedge Fund Activity: Q4 2014 in Review
68 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Syneron Medical Ltd (ELOS) for Q4 2014, worth a combined $252M — down 6.7% from $270M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new ELOS positions and 10 closed out — a net gain of 4 holders — while 19 added to existing stakes and 15 trimmed.
The largest buyer was Senzar Asset Management, opening a new position worth an estimated $2.9M. The largest seller was Baupost Group, cutting an estimated $5.58M.
- 68 institutional investors held Syneron Medical Ltd (ELOS) as of Q4 2014, up from 65 in Q3 2014.
- Funds reported $252M of Syneron Medical Ltd stock for Q4 2014, down 6.7% quarter-over-quarter.
- 14 funds opened new Syneron Medical Ltd positions in Q4 2014 and 10 closed out, a net change of +4 holders.
- The largest Syneron Medical Ltd buyer in Q4 2014 was Senzar Asset Management, an estimated $2.9M added.
- The largest Syneron Medical Ltd seller in Q4 2014 was Baupost Group, an estimated $5.58M sold.
Based on aggregated 13F filings for Q4 2014.